PTC Therapeutics
PTCT
PTCT
280 hedge funds and large institutions have $3.9B invested in PTC Therapeutics in 2025 Q2 according to their latest regulatory filings, with 57 funds opening new positions, 111 increasing their positions, 81 reducing their positions, and 35 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
280
Holders Change
+19
Holders Change %
+7.28%
% of All Funds
3.75%
Holding in Top 10
5
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-16.67%
% of All Funds
0.07%
New
57
Increased
111
Reduced
81
Closed
35
Calls
$13.1M
Puts
$7.7M
Net Calls
+$5.37M
Net Calls Change
+$2.07M
Top Buyers
| 1 |
D.E. Shaw & Co
New York
|
+$48.5M |
| 2 |
Bank of America
Charlotte,
North Carolina
|
+$42.3M |
| 3 |
Pacer Advisors
Malvern,
Pennsylvania
|
+$36.2M |
| 4 |
HRCM
Hood River Capital Management
Palm Beach Gardens,
Florida
|
+$27M |
| 5 |
State Street
Boston,
Massachusetts
|
+$26.4M |
Top Sellers
| 1 |
CCM
Camber Capital Management
Boston,
Massachusetts
|
-$76.4M |
| 2 |
Point72 Asset Management
Stamford,
Connecticut
|
-$70M |
| 3 |
Wellington Management Group
Boston,
Massachusetts
|
-$35.4M |
| 4 |
AC
Armistice Capital
New York
|
-$34.2M |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$33.7M |
